SINTX Technologies (SINT) said Wednesday it published a peer-reviewed study demonstrating that silicon nitride exhibits potent antiviral activity against multiple infectious virus strains, including SARS-CoV-2 and MERS-CoV.

Shares surged about 36% as intraday trading volume soared to nearly 1.6 million from a daily average of roughly 746,000.

Gelteq (GELS) said Friday it plans to commence a preclinical bioequivalence study in September to evaluate its gel-based formulation of a widely used antihistamine for allergy treatment.

Shares surged about 64% as intraday trading volume soared to roughly 61.6 million from a daily average of about 1.41 million.

Broadcom (AVGO) posted a "solid" fiscal Q3, with a significant boost in orders related to AI infrastructure, Truist Securities said in a note emailed Friday.

Broadcom gave several notable AI updates in its recent results, including the addition of a fourth infrastructure customer expected to add $10 billion in sales in H2 of fiscal 2026, ongoing 60% growth from existing AI customers, and an outlook for faster AI growth in fiscal 2027, according to the brokerage.

Shares of Broadcom jumped roughly 11%, with intraday trading volume at over 62.6 million compared with a daily average of about 20 million.

Price: 5.77, Change: +1.39, Percent Change: +31.74